Skip to main content

Aselage Steve

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Aselage Steve as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

BCRX Biocryst Pharmaceuticals Inc

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 29, 2024 (view filing)May 245 daysAselage SteveDirectorPPurchase+2.50K$6.40+$16.0KNew position2.50K after

ACER Acer Therapeutics Inc.

Director2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 1, 2022 (view filing)Nov 292 daysAselage SteveDirectorPPurchase+409.8K$1.22+$500.0K+554.5%483.7K after
Dec 13, 2021 (view filing)Dec 9-104 daysAselage SteveDirectorPPurchase+10.0K$2.06+$20.6K+15.6%73.9K after2 lots

TVTX Travere Therapeutics, Inc.

Director5 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 12, 2022 (view filing)May 111 dayAselage SteveDirectorSSale−2.58K$21.92−$56.4K−1.7%146.9K after
Nov 18, 2021 (view filing)Nov 162 daysAselage SteveDirectorSSale−31.8K$29.39−$934.6K−17.5%149.5K after
Nov 9, 2021 (view filing)Nov 54 daysAselage SteveDirectorSSale−10.0K$26.23−$262.3K−5.8%161.8K after
Nov 3, 2021 (view filing)Nov 1-22 daysAselage SteveDirectorSSale−8.50K$29.69−$252.4K−30.4%19.5K after2 lots
Oct 8, 2021 (view filing)Oct 71 dayAselage SteveDirectorSSale−60.0K$26.25−$1.57M−24.0%189.8K after2 lots